Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics

利用机器学习和单细胞多组学阐明心脏类器官中的 ECM 信号转导

基本信息

  • 批准号:
    10619622
  • 负责人:
  • 金额:
    $ 62.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-09 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary Extracellular matrix (ECM) is the most abundant biomaterial in the body. During cardiac development, the ECM plays critical roles in the formation of shapes and patterns of the heart such as chambers and trabeculae through elaborate interactions with differentiating cells. Although problems in ECM-cell interactions can lead to heart diseases, signaling pathways activated by the specific ECM components are still poorly understood. We recently succeeded in developing human induced pluripotent stem cell-derived cardiac organoids (iPSC-COs) that can recapitulate cardiogenesis. In this multi-PI R01 proposal, our team will further elucidate the mechanisms of ECM- cell interactions that influence cardiac differentiation and morphogenesis. We will apply machine learning and novel iPSC double reporter lines (Tbx5-Clover2-Nkx2.5-TagRFP) to elucidate the effect of cell composition on morphogenesis of iPSC-COs (Aim 1). Afterwards, we will screen 36 different combinations of ECM compositions that can reliably induce iPSC-CO formation using 8 additional iPSC lines for validation (Aim 2). By rigorously analyzing iPSC-COs made with optimized ECM using elastic property measurement and single-cell multiomics, we will elucidate the biological and physical effects associated with ECM signaling and mechanotransduction at single-cell resolution (Aim 3). In summary, understanding the exact role and mechanism of ECM-cell interactions may contribute to finding new biomaterials or therapeutic modalities for treatment of heart diseases.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAYAKUMAR RAJADAS其他文献

JAYAKUMAR RAJADAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAYAKUMAR RAJADAS', 18)}}的其他基金

Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics
利用机器学习和单细胞多组学阐明心脏类器官中的 ECM 信号转导
  • 批准号:
    10435045
  • 财政年份:
    2022
  • 资助金额:
    $ 62.08万
  • 项目类别:
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening
使用 iPSC 微组织和 CRISPR 筛选对阿霉素进行心脏保护治疗
  • 批准号:
    10463762
  • 财政年份:
    2021
  • 资助金额:
    $ 62.08万
  • 项目类别:
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening
使用 iPSC 微组织和 CRISPR 筛选对阿霉素进行心脏保护治疗
  • 批准号:
    10686024
  • 财政年份:
    2021
  • 资助金额:
    $ 62.08万
  • 项目类别:
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening
使用 iPSC 微组织和 CRISPR 筛选对阿霉素进行心脏保护治疗
  • 批准号:
    10296896
  • 财政年份:
    2021
  • 资助金额:
    $ 62.08万
  • 项目类别:

相似海外基金

Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    8013895
  • 财政年份:
    2008
  • 资助金额:
    $ 62.08万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7462657
  • 财政年份:
    2008
  • 资助金额:
    $ 62.08万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7755368
  • 财政年份:
    2008
  • 资助金额:
    $ 62.08万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7586197
  • 财政年份:
    2008
  • 资助金额:
    $ 62.08万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10132461
  • 财政年份:
    1997
  • 资助金额:
    $ 62.08万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10331060
  • 财政年份:
    1997
  • 资助金额:
    $ 62.08万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10597891
  • 财政年份:
    1997
  • 资助金额:
    $ 62.08万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10178913
  • 财政年份:
    1997
  • 资助金额:
    $ 62.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了